Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297941
Status:
RECRUITING
Last Update Posted:
2024-05-02
First Post:
2024-02-23
Brief Title:
Study of REM-422 in Patients With AML or Higher Risk MDS
Sponsor:
Remix Therapeutics
Organization:
Remix Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia Refractory |
| Myelodysplastic Syndromes |
| Higher Risk Myelodysplastic Syndromes |
| Acute Myeloid Leukemia |
Keywords: